Table of Content

1. Executive Summary
   1.1. Global Molecular Imaging Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Epidemiology - Disease Prevalence and Incidence
   3.2. Technology Assessment
   3.3. Regulatory Landscape
   3.4. Value Chain Analysis
   3.5. Key Deals and Mergers
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
   4.3. Global Molecular Imaging Market Outlook: Modality
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2018 - 2022
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
           4.3.3.1. Molecular Ultrasound Imaging
           4.3.3.2. Nuclear Magnetic Resonance (NMR) Spectrometer
           4.3.3.3. Single Photon Emission Computed Tomography (SPECT)
           4.3.3.4. Positron Emission Tomography (PET)
           4.3.3.5. Hybrid Products
   4.4. Market Attractiveness Analysis: Modality
   4.5. Global Molecular Imaging Market Outlook: Application
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2018 - 2022
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
           4.5.3.1. Oncology
           4.5.3.2. Gastrointestinal
           4.5.3.3. Cardiovascular
           4.5.3.4. Neurology
           4.5.3.5. Respiratory
   4.6. Market Attractiveness Analysis: Application
   4.7. Global Molecular Imaging Market Outlook: End Use
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2018 - 2022
       4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
           4.7.3.1. Hospitals
           4.7.3.2. Ambulatory Surgical Centres
           4.7.3.3. Diagnostic Imaging Centres
   4.8. Market Attractiveness Analysis: End Use
5. Global Molecular Imaging Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       6.2.1. By Country
       6.2.2. By Modality
       6.2.3. By Application
       6.2.4. By End Use
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       6.4.1. Molecular Ultrasound Imaging
       6.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       6.4.3. Single Photon Emission Computed Tomography (SPECT)
       6.4.4. Positron Emission Tomography (PET)
       6.4.5. Hybrid Products
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       6.5.1. Oncology
       6.5.2. Gastrointestinal
       6.5.3. Cardiovascular
       6.5.4. Neurology
       6.5.5. Respiratory
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       6.6.1. Hospitals
       6.6.2. Ambulatory Surgical Centres
       6.6.3. Diagnostic Imaging Centres
   6.7. Market Attractiveness Analysis
7. Europe Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       7.2.1. By Country
       7.2.2. By Modality
       7.2.3. By Application
       7.2.4. By End Use
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       7.4.1. Molecular Ultrasound Imaging
       7.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       7.4.3. Single Photon Emission Computed Tomography (SPECT)
       7.4.4. Positron Emission Tomography (PET)
       7.4.5. Hybrid Products
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       7.5.1. Oncology
       7.5.2. Gastrointestinal
       7.5.3. Cardiovascular
       7.5.4. Neurology
       7.5.5. Respiratory
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       7.6.1. Hospitals
       7.6.2. Ambulatory Surgical Centres
       7.6.3. Diagnostic Imaging Centres
   7.7. Market Attractiveness Analysis
8. East Asia Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       8.2.1. By Country
       8.2.2. By Modality
       8.2.3. By Application
       8.2.4. By End Use
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       8.4.1. Molecular Ultrasound Imaging
       8.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       8.4.3. Single Photon Emission Computed Tomography (SPECT)
       8.4.4. Positron Emission Tomography (PET)
       8.4.5. Hybrid Products
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       8.5.1. Oncology
       8.5.2. Gastrointestinal
       8.5.3. Cardiovascular
       8.5.4. Neurology
       8.5.5. Respiratory
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       8.6.1. Hospitals
       8.6.2. Ambulatory Surgical Centres
       8.6.3. Diagnostic Imaging Centres
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       9.2.1. By Country
       9.2.2. By Modality
       9.2.3. By Application
       9.2.4. By End Use
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       9.4.1. Molecular Ultrasound Imaging
       9.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       9.4.3. Single Photon Emission Computed Tomography (SPECT)
       9.4.4. Positron Emission Tomography (PET)
       9.4.5. Hybrid Products
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       9.5.1. Oncology
       9.5.2. Gastrointestinal
       9.5.3. Cardiovascular
       9.5.4. Neurology
       9.5.5. Respiratory
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       9.6.1. Hospitals
       9.6.2. Ambulatory Surgical Centres
       9.6.3. Diagnostic Imaging Centres
   9.7. Market Attractiveness Analysis
10. Latin America Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       10.2.1. By Country
       10.2.2. By Modality
       10.2.3. By Application
       10.2.4. By End Use
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       10.4.1. Molecular Ultrasound Imaging
       10.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       10.4.3. Single Photon Emission Computed Tomography (SPECT)
       10.4.4. Positron Emission Tomography (PET)
       10.4.5. Hybrid Products
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       10.5.1. Oncology
       10.5.2. Gastrointestinal
       10.5.3. Cardiovascular
       10.5.4. Neurology
       10.5.5. Respiratory
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       10.6.1. Hospitals
       10.6.2. Ambulatory Surgical Centres
       10.6.3. Diagnostic Imaging Centres
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Molecular Imaging Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
       11.2.1. By Country
       11.2.2. By Modality
       11.2.3. By Application
       11.2.4. By End Use
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Modality, 2023 - 2031
       11.4.1. Molecular Ultrasound Imaging
       11.4.2. Nuclear Magnetic Resonance (NMR) Spectrometer
       11.4.3. Single Photon Emission Computed Tomography (SPECT)
       11.4.4. Positron Emission Tomography (PET)
       11.4.5. Hybrid Products
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       11.5.1. Oncology
       11.5.2. Gastrointestinal
       11.5.3. Cardiovascular
       11.5.4. Neurology
       11.5.5. Respiratory
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2023 - 2031
       11.6.1. Hospitals
       11.6.2. Ambulatory Surgical Centres
       11.6.3. Diagnostic Imaging Centres
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Hermes Medical Solutions
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Bruker Corporation
       12.3.3. GE Company
       12.3.4. Fujifilm Holdings Corp.
       12.3.5. Koninklijke Philips N.V.
       12.3.6. Siemens AG
       12.3.7. Toshiba Medical System Corp.
       12.3.8. Mirada Medical Limited
       12.3.9. Carestream Health, Inc.
       12.3.10. Esaote SpA
       12.3.11. Positron Corporation
       12.3.12. Medisco Ltd.
       12.3.13. Hitachi Medical Corp.
       12.3.14. MIM Software Inc.
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations